Key result
Left atrial myxoma complicates reperfusion therapy and surgical timing in secondary acute ischemic stroke.
Why the study?
Guidelines lack clear recommendations on mechanical thrombectomy, timing of cardiac surgery, and antithrombotic therapy for large vascular occlusion-acute ischemic stroke associated with atrial myxoma.
Case Report (n=1)
This case report highlights the clinical challenges in diagnosing and managing acute ischemic stroke secondary to left atrial myxoma, including reperfusion strategies and timing of surgical removal.
Answers are grounded in this paper and cite their sources.
Alerts clinicians to diagnostic and timing challenges in myxoma-related stroke; leaves optimal reperfusion and surgical strategies unresolved.
Cerebrovascular events may attribute to the fragmentation of a cardiac tumor. Due to the small number of reported cases of large vascular occlusion-acute ischemic stroke (LVO-AIS) associated with atrial myxoma, current guidelines still follow the principle of intravenous thrombolysis priority, even if LVO-AIS patients are eligible for mechanical thrombectomy, and have not recommended the timing of cardiac surgery or preoperative anticoagulation and antithrombotic therapy. Surgical removal is the definitive therapy for cardiac myxomas, especially for left-sided myxomas. With this case, we aim to demonstrate the main challenges that clinicians may encounter when dealing with patients with AIS secondary to cardiac myxoma: the difficulties with clinical diagnosis, strategies for reperfusion therapy, and therapeutic management of cardiac myxoma.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2023) conducted a case report in Acute ischemic stroke secondary to left atrial myxoma (n=1). Left atrial myxoma presents significant clinical challenges in the diagnosis and management of secondary acute ischemic stroke, particularly regarding reperfusion therapy and surgical timing.
Synapse has enriched 10 related papers. Consider them for comparative context: